Logo

Open Biosystems to be Covalys North American Distributor

May 11, 2005

NEW YORK, May 11 (GenomeWeb Daily News) - Covalys Biosciences and Open Biosystems have signed a distribution and co-development agreement that will make Huntsville, Ala.-based Open Biosystems the sole North American distributor for the Swiss company's protein labeling kits, the companies said today.

 

According to the agreement, Open Biosystems will distribute Covalys' intracellular and in vitro  protein labeling kits to customers in Canada , Mexico , and the US .

 

The two companies also pledged to develop products that combine Open Biosystem's expression and cloning technology with Covalys' protein labeling system in the future.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.